Skip to main content
Supplement Research and Comparison WebsiteBest Price GuaranteeAbout Us
Supplement Research and Comparison Website

Invasive Saccharomyces cerevisiae in a liver transplant patient: case report and review of infection in transplant recipients

  • 2015-05-26
  • Transplant Infectious Disease 17(3)
    • K. Popiel
    • P. Wong
    • M. J. Lee
    • M. Langelier
    • D. Sheppard
    • D. Vinh


Saccharomyces cerevisiae, an ascosporogenous yeast commonly used in the production of food, is an emerging infection in immunocompromised patients. We report the case of a 60-year-old man whose orthotopic liver transplant was complicated by S. cerevisiae fungemia and peritoneal abscess, successfully treated with caspofungin and drainage. We also review the literature of invasive saccharomycoses in recipients of hematologic and solid organ transplants.

Keywords: BMT; SOT; Saccharomyces cerevisiae; fungemia; transplant; yeast.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Saccharomyces cerevisiaeOccurrence of FungemiaHarmful
⬆ Back to top
Unsubscribe anytime. See our Privacy Policy.
Supplement Research and Comparison Website: evidence-based information about supplements, their benefits, potential risks, and their efficacy.

Join Our Community

Statements on this website have not been reviewed by the U.S. Food and Drug Administration. These products are not meant to diagnose, treat, cure, or prevent any disease. The information here is not a replacement for personal medical advice.